Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
BMS is augmenting Zenbexus' efficacy profile in multiple myeloma
BMS has put up the progression-free survival numbers on its recently-approved Zenbexus, more than doubling the score over a control cocktail of DVd.
Fraiser Kansteiner
Oct 8, 2026 2:25pm
For biopharma manufacturing at speed and scale, the future is flexible
Brought to you by
Resilience
Pfizer's Tukysa approved as first-line maintenance therapy
Oct 8, 2026 11:25am
Advancing mCSPC Treatment: A Closer Look at ADT + Darolutamide with Dr. Rana McKay
Brought to you by
Bayer
Viatris acquires Pacira for $1.65B
Oct 8, 2026 11:00am
Argenx calls it quits on Vyvgart Hytrulo Sjögren's disease trial
Oct 8, 2026 10:44am
More News
CSL Seqirus blasted for ‘multiple and prolonged deficiencies’
Oct 8, 2026 10:37am
Theramex and Asieris strike deal for drug-device combo Cevira
Oct 8, 2026 9:00am
PhRMA pushes back on CMS' Part B MFN model in court
Oct 8, 2026 8:05am
Sanofi drafts NBA champ to spread COVID, Nuvaxovid awareness
Oct 7, 2026 2:40pm